Law360
Tyson Provides Road Map For Use Of Sampling In FCA Cases
March 31, 2016
The circumstances under which statistical sampling can be used in order to establish liability in False Claims Act cases remains a controversial issue. Defendants argue that sampling results in a “trial by formula” that can result in ruinous liability based on evidence relating to a relatively small number of claims, while the U.S. Department of Justice and relators’ counsel argue that statistical sampling is an accepted form of evidence, and that limiting its use in FCA cases would have the perverse effect of immunizing the largest frauds from the full scope of liability.
Contacts
Capabilities
Suggested News & Insights
First Circuit Clarifies Application of Medicare’s “Reasonable and Necessary” Standard in FCA Cases Against Clinical LabsDecember 8, 2025Sidley Secures Landmark FCA Defense Victory for Novo NordiskNovember 18, 2025U.S. DOJ Announces Renewal of FCA Working GroupNovember - December 2025U.S. Treasury Launches Departmentwide Review of Preference-Based Contracting ProgramsNovember 11, 2025Torrey Cope Featured on Fierce Biotech's The Top Line Podcast Episode, "Unpacking the FDA Transparency Push on CRLs"October 17, 2025DOJ Announces Renewal of FCA Working GroupOctober 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
